preeclampsia

Showing 1 posts of 1 posts found.

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026
Research and Development DiaMedica, Health Canada, preeclampsia

DiaMedica Therapeutics has received a No Objection Letter (NOL) from Health Canada, giving the company regulatory clearance to start its …

The Gateway to Local Adoption Series

Latest content